Pricing Log in Create free account

Upstream Bio, Inc. (UPB) vs Whitehawk Therapeutics, Inc. (WHWK)

Upstream Bio, Inc. and Whitehawk Therapeutics, Inc. are both Biotechnology companies. Upstream Bio, Inc. and Whitehawk Therapeutics, Inc. are of similar size ($178.4M and $176.9M). Whitehawk Therapeutics, Inc. grew revenue faster over the last twelve months: 16.5% against 16.0%. Whitehawk Therapeutics, Inc. has the higher net margin (0.00% vs −4,955.7%) and the higher return on invested capital (0.00% vs −1,100.9%). Across the 16 metrics below, Whitehawk Therapeutics, Inc. leads on 12 and Upstream Bio, Inc. on 4.

Valuation

Metric UPB WHWK Biotechnology median
P/E n/m n/m 10.60
P/S 55.81 9.34 9.40
P/B 0.65 1.42 2.13
Price to free cash flow n/m n/m 25.18
EV/EBITDA 0.50 n/m 0.66
EV/Sales (26.93) 2.54 9.02
Earnings yield (89.78%) (35.78%) (32.88%)
Free cash flow yield (77.55%) (26.94%) (23.13%)

Profitability

Metric UPB WHWK Biotechnology median
Gross margin 100.00% 88.72% 68.51%
Operating margin (5,382.65%) 0.00% 0.00%
Net margin (4,955.67%) 0.00% 0.00%
Free cash flow margin (4,317.42%) 0.00% 0.00%
Return on equity (46.05%) (44.98%) (51.96%)
Return on assets (44.61%) (42.60%) (46.06%)
Return on invested capital (1,100.93%) 0.00% 0.00%

Growth

Metric UPB WHWK Biotechnology median
Revenue growth (TTM) 15.98% 16.51% 6.76%
EPS growth (last fiscal year) 52.33% 86.02% 29.88%
Revenue growth, 5-year CAGR — (13.29%) 9.75%
Net income growth, 5-year CAGR — 0.00% 0.00%

Health

Metric UPB WHWK Biotechnology median
Debt to equity 0.00 0.00 0.00
Current ratio 27.99 17.38 4.97
Net debt to EBITDA 2.11 1.26 1.01

Dividend

Metric UPB WHWK Biotechnology median
Dividend yield — — 0.41%
Payout ratio — — —

Size

Metric UPB WHWK Biotechnology median
Market cap 176.91m 178.44m 161.82m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack